首页> 美国卫生研究院文献>Cell Death and Differentiation >Biological functions of p53 isoforms through evolution: lessons from animal and cellular models
【2h】

Biological functions of p53 isoforms through evolution: lessons from animal and cellular models

机译:p53亚型通过进化的生物学功能:动物和细胞模型的教训

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The TP53 tumour-suppressor gene is expressed as several protein isoforms generated by different mechanisms, including use of alternative promoters, splicing sites and translational initiation sites, that are conserved through evolution and within the TP53 homologues, TP63 and TP73. Although first described in the eighties, the importance of p53 isoforms in regulating the suppressive functions of p53 has only become evident in the last 10 years, by analogy with observations that p63 and p73 isoforms appeared indispensable to fully understand the biological functions of TP63 and TP73. This review summarizes recent advances in the field of ‘p53 isoforms', including new data on p63 and p73 isoforms. Details of the alternative mechanisms that produce p53 isoforms and cis- and trans-regulators identified are provided. The main focus is on their biological functions (apoptosis, cell cycle, aging and so on) in cellular and animal models, including mouse, zebrafish and Drosophila. Finally, the deregulation of p53 isoform expression in human cancers is reviewed. Based on these latest results, several developments are expected in the future: the identification of drugs modulating p53 isoform expression; the generation of animal models and the evaluation of the use of p53 isoform as biomarkers in human cancers.
机译:TP53肿瘤抑制基因表达为通过不同机制产生的几种蛋白质同工型,包括使用替代的启动子,剪接位点和翻译起始位点,这些蛋白通过进化得以保存并且在TP53同源物TP63和TP73中得以保存。尽管在八十年代首次描述了p53异构体在调节p53抑制功能中的重要性,但直到最近10年才变得明显,与观察到的p63和p73异构体对于充分理解TP63和TP73的生物学功能看来不可或缺。这篇综述总结了“ p53亚型”领域的最新进展,包括有关p63和p73亚型的新数据。提供了产生p53异构体以及已确定的顺式和反式调节子的替代机制的详细信息。主要关注于它们在细胞和动物模型(包括小鼠,斑马鱼和果蝇)中的生物学功能(凋亡,细胞周期,衰老等)。最后,综述了人类癌症中p53亚型表达的失调。基于这些最新结果,未来有望取得一些发展:鉴定调节p53亚型表达的药物;动物模型的产生以及在人类癌症中使用p53亚型作为生物标记物的评估。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号